Who purchased shares of Chemours Co stock, how many, and at what price?

Mary B. Cranston, a director of Chemours Co, purchased 6,000 shares of the company's common stock at $15.825 per share on August 7, 2026, in an open-market transaction.

What was the impact of this purchase on Cranston's total beneficial ownership of Chemours stock?

Following the purchase, Cranston's beneficial ownership of Chemours common stock increased to 113,140.9469 shares, which includes directly owned shares, restricted stock units, and dividend equivalent units.

Chemours Co Director Cranston Purchases 6,000 Shares in Open Market Trade

Aug 11, 2026

Chemours Co director Mary B. Cranston purchased 6,000 shares at $15.825 per share on August 7, 2026, increasing her beneficial ownership to over 113,000 shares according to an SEC Form 4 filing.

Stock Titan

2026-07-06

Chemours CEO Denise Dignam on AI Infrastructure Needs

2026-07-31

NC Gov. Stein Criticizes Chemours-EPA PFAS Settlement; Company Responds

2026-08-11

Chemours Co Director Cranston Purchases 6,000 Shares in Open Market Trade

2026-08-15

Chemours Expands Low-GWP Opteon Refrigerants for AI Data Centers

Chemours Co Director Cranston Purchases 6,000 Shares in Open Market Trade

FAQ